{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:59:36Z","timestamp":1780624776753,"version":"3.54.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-02896-y","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T06:08:05Z","timestamp":1776924485000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting TYRO3 attenuates apoptotic cell\u2013driven cancer stemness in triple negative breast cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Phuong Thao","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Seob","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Cheol","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaewoo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungseok","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong June","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munkyung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miso","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keon Wook","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"2896_CR1","doi-asserted-by":"publisher","first-page":"1465511","DOI":"10.3389\/fonc.2025.1465511","volume":"15","author":"M Darida","year":"2025","unstructured":"Darida M, et al. Improvement in breast cancer survival across molecular subtypes in Hungary between 2011 and 2020: a nationwide, retrospective study. Front Oncol. 2025;15:1465511.","journal-title":"Front Oncol"},{"key":"2896_CR2","doi-asserted-by":"publisher","first-page":"e071674","DOI":"10.1136\/bmj-2022-071674","volume":"381","author":"RA Leon-Ferre","year":"2023","unstructured":"Leon-Ferre RA, Goetz MP. Advances in systemic therapies for triple negative breast cancer. BMJ. 2023;381:e071674.","journal-title":"BMJ"},{"key":"2896_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejca.2020.02.015","volume":"130","author":"G Werutsky","year":"2020","unstructured":"Werutsky G, et al. Locoregional recurrence risk after neoadjuvant chemotherapy: A pooled analysis of nine prospective neoadjuvant breast cancer trials. Eur J Cancer. 2020;130:92\u2013101.","journal-title":"Eur J Cancer"},{"issue":"4","key":"2896_CR4","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.4143\/crt.2015.456","volume":"48","author":"E Jwa","year":"2016","unstructured":"Jwa E, et al. Locoregional recurrence by tumor biology in breast cancer patients after preoperative chemotherapy and breast conservation treatment. Cancer Res treatment: official J Korean Cancer Association. 2016;48(4):1363\u201372.","journal-title":"Cancer Res treatment: official J Korean Cancer Association"},{"issue":"1","key":"2896_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/00130404-200301000-00007","volume":"9","author":"TA Buchholz","year":"2003","unstructured":"Buchholz TA, et al. Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy. Cancer J. 2003;9(1):33\u201341.","journal-title":"Cancer J"},{"issue":"9055","key":"2896_CR6","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(05)61752-7","volume":"349","author":"P Ellis","year":"1997","unstructured":"Ellis P, et al. Preoperative chemotherapy induces apoptosis in early breast cancer. Lancet. 1997;349(9055):849.","journal-title":"Lancet"},{"issue":"3","key":"2896_CR7","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/ijms23031328","volume":"23","author":"O Morana","year":"2022","unstructured":"Morana O, Wood W, Gregory CD. The apoptosis paradox in cancer. Int J Mol Sci. 2022;23(3):1328.","journal-title":"Int J Mol Sci"},{"issue":"15","key":"2896_CR8","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1111\/febs.15624","volume":"288","author":"C Castillo Ferrer","year":"2021","unstructured":"Castillo Ferrer C, Berthenet K, Ichim G. Apoptosis\u2013Fueling the oncogenic fire. FEBS J. 2021;288(15):4445\u201363.","journal-title":"FEBS J"},{"issue":"3","key":"2896_CR9","doi-asserted-by":"publisher","first-page":"e1675","DOI":"10.1038\/cddis.2015.20","volume":"6","author":"V Labi","year":"2015","unstructured":"Labi V, Erlacher M. How cell death shapes cancer. Cell Death Dis. 2015;6(3):e1675\u20131675.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2896_CR10","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s42003-025-08541-7","volume":"8","author":"CE Hagan","year":"2025","unstructured":"Hagan CE, et al. Apoptotic cells promote circulating tumor cell survival and metastasis. Commun Biology. 2025;8(1):1121.","journal-title":"Commun Biology"},{"key":"2896_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6890-13-24","volume":"13","author":"J Alcaide","year":"2013","unstructured":"Alcaide J, et al. The role and prognostic value of apoptosis in colorectal carcinoma. BMC Clin Pathol. 2013;13:1\u20137.","journal-title":"BMC Clin Pathol"},{"issue":"2","key":"2896_CR12","first-page":"319","volume":"5","author":"M Vakkala","year":"1999","unstructured":"Vakkala M, et al. Apoptosis during breast carcinoma progression. Clin Cancer Res. 1999;5(2):319\u201324.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2896_CR13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nrc.2016.58","volume":"16","author":"G Ichim","year":"2016","unstructured":"Ichim G, Tait SW. A fate worse than death: apoptosis as an oncogenic process. Nat Rev Cancer. 2016;16(8):539\u201348.","journal-title":"Nat Rev Cancer"},{"key":"2896_CR14","doi-asserted-by":"crossref","unstructured":"Wang W, et al. Mobilizing phospholipids on tumor plasma membrane implicates phosphatidylserine externalization blockade for cancer immunotherapy. Cell Rep. 2022;41(5):111582.","DOI":"10.1016\/j.celrep.2022.111582"},{"issue":"4","key":"2896_CR15","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1158\/2326-6066.CIR-13-0073","volume":"1","author":"Y Yin","year":"2013","unstructured":"Yin Y, et al. Phosphatidylserine-targeting antibody induces M1 macrophage polarization and promotes myeloid-derived suppressor cell differentiation. Cancer Immunol Res. 2013;1(4):256\u201368.","journal-title":"Cancer Immunol Res"},{"issue":"6","key":"2896_CR16","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1158\/1541-7786.MCR-16-0350","volume":"15","author":"C Kasikara","year":"2017","unstructured":"Kasikara C, et al. Phosphatidylserine sensing by TAM receptors regulates AKT-dependent chemoresistance and PD-L1 expression. Mol Cancer Res. 2017;15(6):753\u201364.","journal-title":"Mol Cancer Res"},{"issue":"13","key":"2896_CR17","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1158\/0008-5472.CAN-20-3320","volume":"81","author":"M Park","year":"2021","unstructured":"Park M, et al. Circulating Small Extracellular Vesicles Activate TYRO3 to Drive Cancer Metastasis and Chemoresistance. Cancer Res. 2021;81(13):3539\u201353.","journal-title":"Cancer Res"},{"issue":"12","key":"2896_CR18","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nrc3847","volume":"14","author":"DK Graham","year":"2014","unstructured":"Graham DK, et al. The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer. Nat Rev Cancer. 2014;14(12):769\u201385.","journal-title":"Nat Rev Cancer"},{"key":"2896_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.canlet.2019.11.028","volume":"470","author":"M Morimoto","year":"2020","unstructured":"Morimoto M, et al. Oncogenic role of TYRO3 receptor tyrosine kinase in the progression of pancreatic cancer. Cancer Lett. 2020;470:149\u201360.","journal-title":"Cancer Lett"},{"issue":"45","key":"2896_CR20","doi-asserted-by":"publisher","first-page":"5872","DOI":"10.1038\/onc.2016.120","volume":"35","author":"C Chien","year":"2016","unstructured":"Chien C, et al. Targeting TYRO3 inhibits epithelial\u2013mesenchymal transition and increases drug sensitivity in colon cancer. Oncogene. 2016;35(45):5872\u201381.","journal-title":"Oncogene"},{"issue":"1","key":"2896_CR21","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/hep.29478","volume":"67","author":"TD Kabir","year":"2018","unstructured":"Kabir TD, et al. A microRNA-7\/growth arrest specific 6\/TYRO3 axis regulates the growth and invasiveness of sorafenib\u2010resistant cells in human hepatocellular carcinoma. Hepatology. 2018;67(1):216\u201331.","journal-title":"Hepatology"},{"issue":"5","key":"2896_CR22","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1158\/0008-5472.CAN-10-2186","volume":"71","author":"E Avilla","year":"2011","unstructured":"Avilla E, et al. Activation of TYRO3\/AXL tyrosine kinase receptors in thyroid cancer. Cancer Res. 2011;71(5):1792\u2013804.","journal-title":"Cancer Res"},{"issue":"8","key":"2896_CR23","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41568-019-0168-y","volume":"19","author":"F Zanconato","year":"2019","unstructured":"Zanconato F, Cordenonsi M, Piccolo S. YAP and TAZ: a signalling hub of the tumour microenvironment. Nat Rev Cancer. 2019;19(8):454\u201364.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"2896_CR24","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jhep.2021.05.018","volume":"75","author":"X Song","year":"2021","unstructured":"Song X, et al. Focal adhesion kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation. J Hepatol. 2021;75(4):888\u201399.","journal-title":"J Hepatol"},{"issue":"10","key":"2896_CR25","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1158\/1541-7786.MCR-18-0158","volume":"16","author":"T Sugihara","year":"2018","unstructured":"Sugihara T, et al. YAP tyrosine phosphorylation and nuclear localization in cholangiocarcinoma cells are regulated by LCK and independent of LATS activity. Mol Cancer Res. 2018;16(10):1556\u201367.","journal-title":"Mol Cancer Res"},{"key":"2896_CR26","doi-asserted-by":"publisher","first-page":"114350","DOI":"10.1016\/j.biopha.2023.114350","volume":"160","author":"Y Li","year":"2023","unstructured":"Li Y, et al. Luteolin directly binds to KDM4C and attenuates ovarian cancer stemness via epigenetic suppression of PPP2CA\/YAP axis. Biomed Pharmacother. 2023;160:114350.","journal-title":"Biomed Pharmacother"},{"key":"2896_CR27","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.biopha.2018.06.028","volume":"105","author":"J Qin","year":"2018","unstructured":"Qin J, et al. Tanshinone IIA inhibits cervix carcinoma stem cells migration and invasion via inhibiting YAP transcriptional activity. Biomed Pharmacother. 2018;105:758\u201365.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"2896_CR28","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1038\/s41416-020-0827-5","volume":"122","author":"Y Gao","year":"2020","unstructured":"Gao Y, et al. Stearoyl-CoA-desaturase-1 regulates gastric cancer stem-like properties and promotes tumour metastasis via Hippo\/YAP pathway. Br J Cancer. 2020;122(12):1837\u201347.","journal-title":"Br J Cancer"},{"issue":"4","key":"2896_CR29","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1158\/1078-0432.CCR-13-1854","volume":"20","author":"Y Touil","year":"2014","unstructured":"Touil Y, et al. Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes\/YAP axis. Clin Cancer Res. 2014;20(4):837\u201346.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2896_CR30","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1158\/0008-5472.CAN-20-2801","volume":"81","author":"HM Quinn","year":"2021","unstructured":"Quinn HM, et al. YAP and \u03b2-catenin cooperate to drive oncogenesis in basal breast cancer. Cancer Res. 2021;81(8):2116\u201327.","journal-title":"Cancer Res"},{"key":"2896_CR31","doi-asserted-by":"publisher","first-page":"101608","DOI":"10.1016\/j.tranon.2022.101608","volume":"28","author":"K Hara","year":"2023","unstructured":"Hara K, et al. TYRO3 promotes chemoresistance via increased LC3 expression in pancreatic cancer. Translational Oncol. 2023;28:101608.","journal-title":"Translational Oncol"},{"issue":"5","key":"2896_CR32","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/s41401-022-01029-8","volume":"44","author":"YJ Lee","year":"2023","unstructured":"Lee YJ, et al. Circulating small extracellular vesicles promote proliferation and migration of vascular smooth muscle cells via AXL and MerTK activation. Acta Pharmacol Sin. 2023;44(5):984\u201398.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"2896_CR33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.canlet.2009.04.044","volume":"285","author":"S Aroui","year":"2009","unstructured":"Aroui S, et al. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231. Cancer Lett. 2009;285(1):28\u201338.","journal-title":"Cancer Lett"},{"issue":"6","key":"2896_CR34","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/ijc.11330","volume":"106","author":"T Hiraga","year":"2003","unstructured":"Hiraga T, et al. Effects of oral UFT combined with or without zoledronic acid on bone metastasis in the 4T1\/luc mouse breast cancer. Int J Cancer. 2003;106(6):973\u20139.","journal-title":"Int J Cancer"},{"issue":"20","key":"2896_CR35","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1038\/onc.2013.209","volume":"33","author":"X Lu","year":"2014","unstructured":"Lu X, et al. The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis. Oncogene. 2014;33(20):2655\u201364.","journal-title":"Oncogene"},{"key":"2896_CR36","doi-asserted-by":"crossref","unstructured":"Xu J, et al. ATP11B inhibits breast cancer metastasis in a mouse model by suppressing externalization of nonapoptotic phosphatidylserine. J Clin Investig. 2022;132(5):e149473.","DOI":"10.1172\/JCI149473"},{"key":"2896_CR37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0065-230X(08)00002-X","volume":"100","author":"RM Linger","year":"2008","unstructured":"Linger RM, et al. TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv Cancer Res. 2008;100:35\u201383.","journal-title":"Adv Cancer Res"},{"issue":"31","key":"2896_CR38","doi-asserted-by":"publisher","first-page":"18355","DOI":"10.1074\/jbc.271.31.18355","volume":"271","author":"L Ling","year":"1996","unstructured":"Ling L, Templeton D, Kung H-J. Identification of the major autophosphorylation sites of Nyk\/Mer, an NCAM-related receptor tyrosine kinase. J Biol Chem. 1996;271(31):18355\u201362.","journal-title":"J Biol Chem"},{"issue":"2","key":"2896_CR39","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41388-019-0988-y","volume":"39","author":"T Azad","year":"2020","unstructured":"Azad T, et al. A gain-of-functional screen identifies the Hippo pathway as a central mediator of receptor tyrosine kinases during tumorigenesis. Oncogene. 2020;39(2):334\u201355.","journal-title":"Oncogene"},{"issue":"1","key":"2896_CR40","doi-asserted-by":"publisher","first-page":"p105","DOI":"10.1038\/s41420-018-0124-8","volume":"4","author":"Y-W Li","year":"2018","unstructured":"Li Y-W, et al. Apigenin suppresses the stem cell-like properties of triple-negative breast cancer cells by inhibiting YAP\/TAZ activity. Cell death discovery. 2018;4(1):p105.","journal-title":"Cell death discovery"},{"issue":"19","key":"2896_CR41","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1111\/febs.16091","volume":"289","author":"H Kwon","year":"2022","unstructured":"Kwon H, Kim J, Jho Eh. Role of the Hippo pathway and mechanisms for controlling cellular localization of YAP\/TAZ. FEBS J. 2022;289(19):5798\u2013818.","journal-title":"FEBS J"},{"issue":"12","key":"2896_CR42","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1038\/s41401-024-01342-4","volume":"45","author":"X-j Shen","year":"2024","unstructured":"Shen X-j, et al. Adaptor protein CEMIP reduces the chemosensitivity of small cell lung cancer via activation of an SRC-YAP oncogenic module. Acta Pharmacol Sin. 2024;45(12):2657\u201371.","journal-title":"Acta Pharmacol Sin"},{"issue":"8","key":"2896_CR43","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.chembiol.2021.02.019","volume":"28","author":"D Zhao","year":"2021","unstructured":"Zhao D, et al. Scribble sub-cellular localization modulates recruitment of YES1 to regulate YAP1 phosphorylation. Cell Chem Biology. 2021;28(8):1235\u201341. e5.","journal-title":"Cell Chem Biology"},{"issue":"9","key":"2896_CR44","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1007\/s00018-021-03781-2","volume":"78","author":"L LeBlanc","year":"2021","unstructured":"LeBlanc L, Ramirez N, Kim J. Context-dependent roles of YAP\/TAZ in stem cell fates and cancer. Cell Mol Life Sci. 2021;78(9):4201\u201319.","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"2896_CR45","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/cr.2015.101","volume":"25","author":"X Dai","year":"2015","unstructured":"Dai X, et al. YAP activates the Hippo pathway in a negative feedback loop. Cell Res. 2015;25(10):1175\u20138.","journal-title":"Cell Res"},{"key":"2896_CR46","doi-asserted-by":"crossref","unstructured":"Park M, et al. TYRO3 blockade enhances anti-PD-1 therapy response by modulating expression of CCN1 in tumor microenvironment. J Immunother Cancer. 2023;11(1):e006084.","DOI":"10.1136\/jitc-2022-006084"},{"issue":"2","key":"2896_CR47","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/bkcs.12167","volume":"42","author":"Y Kim","year":"2021","unstructured":"Kim Y, et al. Design and Synthesis of 5-Aryl\u2010substituted Phenylpyrimidine\u20102, 4\u2010diamine Derivatives as Novel Mer and Tyro3 Kinase Inhibitors. Bull Korean Chem Soc. 2021;42(2):206\u201311.","journal-title":"Bull Korean Chem Soc"},{"issue":"8","key":"2896_CR48","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1016\/j.celrep.2017.02.001","volume":"18","author":"H Lu","year":"2017","unstructured":"Lu H, et al. Chemotherapy-induced Ca2\u2009+\u2009release stimulates breast cancer stem cell enrichment. Cell Rep. 2017;18(8):1946\u201357.","journal-title":"Cell Rep"},{"issue":"1","key":"2896_CR49","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1476-4598-12-24","volume":"12","author":"K Abubaker","year":"2013","unstructured":"Abubaker K, et al. Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden. Mol Cancer. 2013;12(1):24.","journal-title":"Mol Cancer"},{"issue":"2","key":"2896_CR50","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1158\/1535-7163.MCT-10-0788","volume":"10","author":"S Rizzo","year":"2011","unstructured":"Rizzo S, et al. Ovarian cancer stem cell\u2013like side populations are enriched following chemotherapy and overexpress EZH2. Mol Cancer Ther. 2011;10(2):325\u201335.","journal-title":"Mol Cancer Ther"},{"issue":"33","key":"2896_CR51","doi-asserted-by":"publisher","first-page":"pE4600","DOI":"10.1073\/pnas.1513433112","volume":"112","author":"H Lu","year":"2015","unstructured":"Lu H, et al. Chemotherapy triggers HIF-1\u2013dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype. Proc Natl Acad Sci. 2015;112(33):pE4600\u2013E4609.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"2896_CR52","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12964-023-01088-2","volume":"21","author":"Y-T Chan","year":"2023","unstructured":"Chan Y-T, et al. The interplay between IGF-1R signaling and Hippo-YAP in breast cancer stem cells. Cell Communication Signal. 2023;21(1):81.","journal-title":"Cell Communication Signal"},{"issue":"1","key":"2896_CR53","doi-asserted-by":"publisher","first-page":"10186","DOI":"10.1038\/ncomms10186","volume":"6","author":"T Kim","year":"2015","unstructured":"Kim T, et al. A basal-like breast cancer-specific role for SRF\u2013IL6 in YAP-induced cancer stemness. Nat Commun. 2015;6(1):10186.","journal-title":"Nat Commun"},{"issue":"1","key":"2896_CR54","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s11033-025-10264-1","volume":"52","author":"PD Talukdar","year":"2025","unstructured":"Talukdar PD, Roy H, Chatterji U. Targeting breast cancer stem cells in ER-positive breast cancer by repurposing the benzoporphyrin derivative verteporfin as a YAP\/TAZ small molecule inhibitor. Mol Biol Rep. 2025;52(1):154.","journal-title":"Mol Biol Rep"},{"issue":"5","key":"2896_CR55","doi-asserted-by":"publisher","first-page":"331","DOI":"10.6004\/jnccn.2024.0035","volume":"22","author":"WJ Gradishar","year":"2024","unstructured":"Gradishar WJ, et al. Breast cancer, version 3.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2024;22(5):331\u201357.","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02896-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02896-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02896-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:02:45Z","timestamp":1780621365000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02896-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2896"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02896-y","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in accordance with institutional regulations and approved by the Seoul National University Institutional Animal Care and Use Committee (Approval #SNU-230822-6-1, SNU-250121-4-1, SNU-251230-4).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"333"}}